PRTN3 variant correlates with increased autoantigen levels and relapse risk in PR3-ANCA versus MPO-ANCA disease
Open Access
- 22 February 2023
- journal article
- research article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 8 (4)
Abstract
A GWAS of patients with anti-neutrophil cytoplasmic antibodies (ANCAs) found an association between proteinase-3 ANCA (PR3-ANCA) and a single nucleotide polymorphism (rs62132293) upstream of PRTN3 , encoding PR3. The variant (G allele) was shown to be an expression quantitative trait locus in healthy controls, but the clinical impact remains unknown. Longitudinally followed patients with ANCA and healthy controls were genotyped. Gene expression was quantified by real-time quantitative PCR from leukocyte RNA. Plasma PR3 was quantified by ELISA. Among patients, variant carriers had elevated leukocyte PRTN3 expression compared with noncarriers (C/G vs. C/C and G/G vs. C/C). Healthy controls had low PRTN3 regardless of genotype. Myeloperoxidase ( MPO ) expression did not differ by genotype. PRTN3 expression correlated with circulating PR3, and variant carriers had higher plasma PR3 compared with noncarriers. Among variant carriers, there was an increased risk of relapse in patients with PR3-ANCA versus MPO-ANCA. The risk allele marked by rs62132293 is clinically significant as it is associated with increased autoantigen and may, in part, explain increased relapse in PR3-ANCA. Our results underscore the role of autoantigen availability in ANCA vasculitis.Keywords
Funding Information
- National Institute of Diabetes and Digestive and Kidney Diseases (T32DK007750)
- National Institute of Diabetes and Digestive and Kidney Diseases (PI RJ Falk)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01 DK125350-02)
This publication has 26 references indexed in Scilit:
- Dysregulation of Autoantigen Genes in ANCA-Associated Vasculitis Involves Alternative Transcripts and New Protein SynthesisJournal of the American Society of Nephrology, 2015
- Genetically Determined Severity of Anti-Myeloperoxidase GlomerulonephritisThe American Journal of Pathology, 2013
- 2012 Revised International Chapel Hill Consensus Conference Nomenclature of VasculitidesArthritis & Rheumatism, 2012
- Genetically Distinct Subsets within ANCA-Associated VasculitisNew England Journal of Medicine, 2012
- Are there specific genetic risk factors for the different forms of ANCA-associated vasculitis?Annals of the Rheumatic Diseases, 2011
- Epigenetic basis for aberrant upregulation of autoantigen genes in humans with ANCA vasculitisJournal of Clinical Investigation, 2010
- Novel expression signatures identified by transcriptional analysis of separated leucocyte subsets in systemic lupus erythematosus and vasculitisAnnals of the Rheumatic Diseases, 2010
- Increased neutrophil membrane expression and plasma level of proteinase 3 in systemic vasculitis are not a consequence of the − 564 A/G promotor polymorphismClinical and Experimental Immunology, 2006
- Circumvention of Normal Constraints on Granule Protein Gene Expression in Peripheral Blood Neutrophils and Monocytes of Patients with Antineutrophil Cytoplasmic Autoantibody–Associated GlomerulonephritisJournal of the American Society of Nephrology, 2004
- Increased circulating levels of proteinase 3 in patients with anti-neutrophilic cytoplasmic autoantibodies-associated systemic vasculitis in remissionClinical and Experimental Immunology, 2003